Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19214139 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence
Conditions: Opioid Withdrawal;   Physical Dependence
Intervention: Drug: Ondansetron

Study has passed its completion date and status has not been verified in more than two years.